Nema Health

Nema Health is a spin-off of the Universitat de Lleida and the Vall d'Hebrón Institut de Recerca (VHIR), developing ONCONEOVAC, a personalized immunotherapy for the treatment of cancer. ONCONEOVAC is based on the therapeutic effect induced by antigens extracted from the patient's tumor biopsy when formulated with proprietary peptides, activating an immune response against each patient's unique cancer and becoming an effective and non-toxic treatment. By providing a new treatment option (stand alone or in combination with the standard of care), it can significantly enhance patient survival and quality of life. We are currently in pre-clinical stage.